60 DEGREES PHARMACEUTICALS INC. - COMMON STOCK
0.2187
08-May-24 14:57:07
15 minutes delayed
Stocks
+0.0172
+8.54%
Today's range
0.2020 - 0.2352
ISIN
N/A
Source
NASDAQ
-
08 May 2024 06:59:00 By Nasdaq GlobeNewswire
-
02 May 2024 06:59:00 By Nasdaq GlobeNewswire
-
60 Degrees Pharmaceuticals to Sponsor Pilot Study of Tafenoquine for Treatment of Canine Babesiosis
03 Apr 2024 06:58:00 By Nasdaq GlobeNewswire
-
14 Mar 2024 06:59:00 By Nasdaq GlobeNewswire
-
20 Feb 2024 06:59:00 By Nasdaq GlobeNewswire
-
60 Degrees Pharmaceuticals Appoints Kristen Landon as Chief Commercial Officer
08 Feb 2024 06:59:00 By Nasdaq GlobeNewswire
-
60 Degrees Pharmaceuticals Announces Closing of $2.4 Million Public Offering
31 Jan 2024 10:15:00 By Nasdaq GlobeNewswire
-
60 Degrees Pharmaceuticals Announces Pricing of $2.4 Million Public Offering
30 Jan 2024 08:00:00 By Nasdaq GlobeNewswire
-
60 Degrees Pharma Plans Pivotal Babesiosis Study with Tafenoquine Following Jan 17 FDA Meeting
22 Jan 2024 06:59:00 By Nasdaq GlobeNewswire
-
60 Degrees Pharma Regains Compliance with Nasdaq Listing Requirements
16 Jan 2024 06:59:00 By Nasdaq GlobeNewswire
-
15 Nov 2023 06:29:00 By Nasdaq GlobeNewswire
-
19 Oct 2023 07:31:00 By Nasdaq GlobeNewswire
-
12 Oct 2023 15:16:00 By Nasdaq GlobeNewswire
-
18 Sep 2023 15:16:00 By Nasdaq GlobeNewswire
-
06 Sep 2023 06:31:00 By Nasdaq GlobeNewswire
-
30 Aug 2023 06:32:00 By Nasdaq GlobeNewswire
-
22 Aug 2023 06:31:00 By Nasdaq GlobeNewswire
-
15 Aug 2023 06:31:00 By Nasdaq GlobeNewswire
-
31 Jul 2023 06:59:00 By Nasdaq GlobeNewswire
- <<
- <
- 1
- >